secwatch.observer — SEC 8-K summary
======================================

Issuer:     Adagio Medical Holdings, Inc. (ADGM)
CIK:        0002006986
Form:       8-K
Filed at:   2026-06-12T20:32:32+00:00
Accession:  0001104659-26-073517
Event type: regulatory
Sentiment:  negative
Materiality: 0.60
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Adagio Medical receives Nasdaq notice for bid price < $1; 180-day cure period until Dec 9, 2026
--------------------------------------------------------------------------------

- Notice from Nasdaq on June 12, 2026 for non-compliance with Listing Rule 5550(a)(2) (min $1 bid).
- Stock continues trading on Nasdaq Capital Market during 180-day cure period ending Dec 9, 2026.
- To regain compliance, bid price must close at or above $1 for at least 10 consecutive trading days.
- Second 180-day period may be available if necessary; delisting possible if non-compliance persists.
- Company considering options including reverse stock split to meet bid price requirement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2006986/000110465926073517/0001104659-26-073517-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2006986/000110465926073517/tm2617882d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-073517

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer